0
Summaries for Patients |

Vitamin E Supplements May Be Harmful FREE

[+] Article and Author Information

The summary below is from the full report titled “Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality.” It is in the 4 January 2005 issue of Annals of Internal Medicine (volume 142, pages 37-46). The authors are E.R. Miller III, R. Pastor-Barriuso, D. Dalal, R.A. Riemersma, L.J. Appel, and E. Guallar.


Ann Intern Med. 2005;142(1):I-40. doi:10.7326/0003-4819-142-1-200501040-00111
Text Size: A A A

What is the problem and what is known about it so far?

Vitamin E (sometimes called alpha-tocopherol) is in many foods, including nuts, oils, and vegetables. People in western countries usually consume small but adequate amounts of this vitamin in their diets. People also can buy multivitamins and supplements that contain vitamin E. Each multivitamin often contains about 30 international units (IU) of vitamin E. Many experts recommend this daily amount for adults. Supplements often contain much larger amounts, such as 200, 400, or 1000 IU. Some research suggests that taking vitamin E supplements may boost immune systems and prevent heart disease and some types of cancer. Other research suggests that taking large amounts of vitamin E as supplements may increase risks for bleeding problems and death. Because of these risks, some experts set 1500 IU daily as the upper tolerable intake level for vitamin E. To make good decisions about taking or not taking vitamin E, people need information about its safety.

Why did the researchers do this particular study?

To summarize data about the safety of different amounts of vitamin E taken as supplements by adults.

Who was studied?

135,967 adults who had participated in 19 studies. Many were older than 60 years of age. About 60% had heart disease or a risk factor for heart disease, such as tobacco use and high blood pressure.

How was the study done?

The researchers looked at deaths reported in 19 randomized trials that compared vitamin E with either a dummy pill (placebo) or no treatment. They searched medical literature up to August 2004 to find these trials. Each trial lasted longer than 1 year. Amounts of vitamin E tested in the trials ranged from 16.5 IU daily to 2000 IU daily. The researchers combined data from the trials to examine mortality among people taking different amounts of vitamin E.

What did the researchers find?

Compared with placebo or no treatment, intake of vitamin E in amounts of 400 IU or more daily for longer than 1 year increased the risk for death. Whether lower amounts of vitamin E increased or decreased the risk for death was unclear.

What were the limitations of the study?

Trials that tested high amounts of vitamin E often involved older adults with chronic diseases. Findings from these trials may not apply to younger, healthy adults. Some trials assessed multivitamin combinations rather than vitamin E alone. The review did not find the exact lowest amount of vitamin E that was associated with increased risk for death.

What are the implications of the study?

Adults should avoid taking vitamin E preparations in amounts of 400 IU or more. Experts should reconsider the stated upper tolerable intake level of vitamin E. Sellers should consider removing vitamin preparations that contain 400 IU or more per dose from stores.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Point of Care
Topic Collections
PubMed Articles

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)